MAPK3 and renal cell carcinoma: METTL14 downregulation in cancer cells decreases the m6A levels in P2RX6 mRNA, thereby increasing its expression which leads to ERK1/2 MAPK pathway activation promoting RCC cell migration and invasion [50].